Market Research Logo

Global Antiretroviral Therapy Market 2017-2021

Global Antiretroviral Therapy Market 2017-2021

About Antiretroviral Therapy

The antiretroviral therapy (ART) market is primarily related to the treatment of human immunodeficiency virus (HIV) infection. Antiretroviral drugs are usually taken in combination to prevent the growth of the virus, which slows the growth of HIV infection. The major drivers for the ART market include the rising awareness of retroviral infection, aggressive innovation in diagnostic techniques, the introduction of novel drugs through significant investments made in R&D, and high unmet needs in the retrovirus infection treatment domain.

Technavio’s analysts forecast the global antiretroviral therapy market to grow at a CAGR of 2.64% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global antiretroviral therapy market for 2017-2021. To calculate the market size, the report considers the sales of branded, generic, and off-label drugs.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Antiretroviral Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Gilead
  • ViiV Healthcare
  • Janssen Pharmaceuticals
  • F. Hoffmann-La Roche
Other prominent vendors
  • Abbvie
  • Boehringer Ingelheim
  • Bionor Pharma
  • Vertex Pharmaceuticals
  • Mylan
Market driver
  • Rising awareness of retroviral infection
  • For a full, detailed list, view our report
Market challenge
  • High cost of antiretroviral drugs
  • For a full, detailed list, view our report
Market trend
  • Significant pipeline
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?


Press Release

Technavio Announces the Publication of its Research Report – Global Antiretroviral Therapy Market 2017-2021

Technavio recognizes the following companies as the key players in the global antiretroviral therapy market: Gilead, ViiV Healthcare, Janssen Pharmaceuticals, and F. Hoffmann-La Roche

Other Prominent Vendors in the market are: Abbvie, Boehringer Ingelheim, Bionor Pharma, Vertex Pharmaceuticals, and Mylan

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is Significant pipeline. Several promising antiretroviral agents are in the pipeline, which will boost the market growth in the long run. The approval of new therapeutic agents will broaden the options available for treatment and thus will lead to the increase in demand for therapeutic regimens. There are approximately 37 molecules under different clinical trial stages globally of which 18 molecules are in phase-II, and 13 molecules are in phase-III for various retroviral malignancies. The remaining molecules are in phase-I of their clinical trials.”

According to the report, one of the major drivers for this market is Rising awareness of retroviral infection. The awareness about retroviral infection is on the rise. Initiatives such as the Centers for Disease Control and Prevention's (CDC's) Act Against AIDS, targeted to make the youth aware of the risk of HIV infection because of concurrent use of alcohol and drugs, will drive the growth of the market. The initiatives by various governments also help to create awareness.

Further, the report states that one of the major factors hindering the growth of this market is High cost of antiretroviral drugs. High cost of treatment is one of the major challenges impeding the growth of the global ART market. The majority of patients in low and middle-income countries infected with HIV-1 and diagnosed after confirmatory tests fail to complete the course of treatment due to affordability concerns. According to the NIH, ART's success depends on patient adherence to the therapy course. Patients who had adhered 95% or above have shown a decrease in the viral load; the HIV RNA level was also non-detectable. Hence, the market can only experience growth if demand is high, which can only be possible if individuals are able to afford the cost of treatment. Therefore, it is essential to bring down the cost of drugs and treatment so that drug adherence, as well as adoption rate, improves.

Companies Mentioned

Gilead, ViiV Healthcare, Janssen Pharmaceuticals, F. Hoffmann-La Roche, Abbvie, Boehringer Ingelheim, Bionor Pharma, Vertex Pharmaceuticals, and Mylan

  • Executive summary
  • Scope of the report
  • Research methodology
  • Introduction
    • Market outline
  • Disease overview
  • Market landscape
    • Market overview
      • Table Global ART market
    • Market size and forecast
      • Table Global ART market 2016-2021 ($ millions)
    • Five forces analysis
      • Table Five forces analysis
  • Pipeline landscape
    • Table Pipeline landscape by development phase
    • Table Key clinical trials
  • Market segmentation by drug class
    • Table Global ART market by drug class 2016
    • Table Global ART market by drug class 2021
    • Multiclass combination products
      • Table Global ART market by multiclass combination products 2016-2021 ($ millions)
    • NRTIs
      • Table Global ART market by NRTIs 2016-2021 ($ millions)
    • Integrase inhibitors
      • Table Global ART market by integrase inhibitors 2016-2021 ($ millions)
    • NNRTIs
      • Table Global ART market by NNRTIs 2016-2021 ($ millions)
    • Others
      • Table Global ART market by others 2016-2021 ($ millions)
  • Regional landscape
    • Table Global ART market: Regional landscape
    • Regional comparison
      • Table Regional comparison
    • ART market in Americas
      • Table ART market in Americas 2016-2021 ($ millions)
      • Table ART market in Americas - Year over year growth 2017-2021
    • ART market in EMEA
      • Table ART market in EMEA 2016-2021 ($ millions)
      • Table ART market in EMEA - Year over year growth 2017-2021
    • ART market in APAC
      • Table ART market in APAC 2016-2021 ($ millions)
      • Table ART market in APAC - Year over year growth 2017-2021
    • Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • Significant pipeline
    • Advanced formulations
    • Funding and treatment initiatives
  • Vendor landscape
  • Key vendor analysis
    • Gilead
      • Table Gilead: Key highlights
      • Table Gilead: Strength assessment
      • Table Gilead: Strategy assessment
      • Table Gilead: Opportunity assessment
    • ViiV Healthcare
      • Table ViiV Healthcare: Key highlights
      • Table ViiV Healthcare: Strength assessment
      • Table ViiV Healthcare: Strategy assessment
      • Table ViiV Healthcare: Opportunity assessment
    • Janssen Pharmaceuticals
      • Table Janssen Pharmaceuticals: Key highlights
      • Table Janssen Pharmaceuticals: Strength assessment
      • Table Janssen Pharmaceuticals: Strategy assessment
      • Table Janssen Pharmaceuticals: Opportunity assessment
    • F. Hoffmann-La Roche
      • Table F. Hoffmann-La Roche: Key highlights
      • Table F. Hoffmann-La Roche: Strength assessment
      • Table F. Hoffmann-La Roche: Strategy assessment
      • Table F. Hoffmann-La Roche: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report